• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自两个民族文化群体的健康BRCA携带者的文化方面

Cultural aspects of healthy BRCA carriers from two ethnocultural groups.

作者信息

Navarro de Souza Alicia, Groleau Danielle, Loiselle Carmen G, Foulkes William D, Wong Nora

机构信息

1Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Qual Health Res. 2014 May;24(5):665-81. doi: 10.1177/1049732314528756. Epub 2014 Apr 1.

DOI:10.1177/1049732314528756
PMID:24692182
Abstract

We explored the experiences of Ashkenazi Jewish and French Canadian women and meanings attributed to their hereditary breast and ovarian cancer (HBOC) risk. We purposively sampled 40 BRCA1 or BRCA2 (BRCA) mutation carriers and conducted theoretically driven semistructured interviews. According to content analysis, participants from these two ethnocultural groups held divergent meanings associated with being a BRCA carrier and different views pertaining to the illness experience and risk awareness. All participants identified a genetic basis; however, the French Canadian women also expressed other causes. The French Canadian women reported not knowing other carriers in their social environment, whereas the Ashkenazi Jewish women emphasized a strong sense of community contributing to their ethnic risk awareness. Based on these findings, we suggest that French Canadian women could benefit from greater awareness of the HBOC genetic risk and that health care providers should consider ethnically related and individual-based experiences and meanings during counseling.

摘要

我们探究了德系犹太裔和法裔加拿大女性的经历,以及她们对遗传性乳腺癌和卵巢癌(HBOC)风险的认知。我们有目的地抽取了40名BRCA1或BRCA2(BRCA)基因突变携带者,并进行了理论驱动的半结构化访谈。根据内容分析,这两个种族文化群体的参与者对于成为BRCA携带者有着不同的认知,对疾病经历和风险意识也有不同的看法。所有参与者都确定了遗传基础;然而,法裔加拿大女性也提到了其他病因。法裔加拿大女性表示在她们的社交圈子里不认识其他携带者,而德系犹太裔女性则强调强烈的社区意识有助于她们了解种族风险。基于这些发现,我们建议法裔加拿大女性可以从提高对HBOC遗传风险的认识中受益,并且医疗保健提供者在咨询过程中应考虑种族相关及基于个体的经历和认知。

相似文献

1
Cultural aspects of healthy BRCA carriers from two ethnocultural groups.来自两个民族文化群体的健康BRCA携带者的文化方面
Qual Health Res. 2014 May;24(5):665-81. doi: 10.1177/1049732314528756. Epub 2014 Apr 1.
2
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.BRCA突变携带者中按种族和突变位置划分的基因型-表型相关性
Breast J. 2015 May-Jun;21(3):260-7. doi: 10.1111/tbj.12392. Epub 2015 Mar 19.
3
The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.1100delAT BRCA1和8765delAG BRCA2突变:在高危非阿什肯纳兹犹太人中的发生情况以及犹太和非犹太携带者的单倍型比较
Fam Cancer. 2004;3(1):11-4. doi: 10.1023/B:FAME.0000026837.32470.b4.
4
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。
Clin Cancer Res. 2002 Dec;8(12):3776-81.
5
Familial communication and cascade testing among relatives of BRCA population screening participants.BRCA 人群筛查参与者亲属中的家族沟通和级联检测。
Genet Med. 2018 Nov;20(11):1446-1454. doi: 10.1038/gim.2018.26. Epub 2018 Mar 29.
6
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.针对阿什肯纳兹犹太人群体进行癌症易感基因BRCA1/BRCA2突变的群体检测:一项随机对照试验。
J Natl Cancer Inst. 2014 Nov 30;107(1):379. doi: 10.1093/jnci/dju379. Print 2015 Jan.
7
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.对接受过遗传咨询的BRCA1或BRCA2基因突变男性携带者的需求评估。
Am J Hum Genet. 2000 Dec;67(6):1494-504. doi: 10.1086/316907. Epub 2000 Nov 3.
8
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.MDM2基因单核苷酸多态性309加速了犹太裔阿什肯纳兹血统的BRCA1和BRCA2携带者的乳腺癌和卵巢癌发生。
Breast Cancer Res Treat. 2008 Oct;111(3):497-504. doi: 10.1007/s10549-007-9797-z. Epub 2007 Nov 18.
9
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.以色列裔犹太 BRCA1/2 基因突变携带者的子宫癌。
Cancer. 2019 Mar 1;125(5):698-703. doi: 10.1002/cncr.31842. Epub 2018 Nov 29.
10
Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers.生育治疗与以色列裔犹太 BRCA1 或 BRCA2 基因突变携带者侵袭性上皮性卵巢癌风险。
Fertil Steril. 2015 May;103(5):1305-12. doi: 10.1016/j.fertnstert.2015.02.011. Epub 2015 Mar 16.

引用本文的文献

1
A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1/2 gene alteration: "So many little, little traumas could have been avoided".对 BRCA1/2 基因突变相关身份认同体验的定性反思性主题分析:“本可以避免这么多小创伤”。
BMC Health Serv Res. 2022 Aug 6;22(1):1007. doi: 10.1186/s12913-022-08372-w.
2
Prospective Validation of the Decalogue, a Set of Doctor-Patient Communication Recommendations to Improve Patient Illness Experience and Mood States within a Hospital Cardiologic Ambulatory Setting.《Decalogue》的前瞻性验证,这是一套医生与患者沟通建议,旨在改善医院心内科门诊环境下患者的疾病体验和情绪状态。
Biomed Res Int. 2017;2017:2792131. doi: 10.1155/2017/2792131. Epub 2017 Nov 21.
3
Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.
乌克兰卵巢癌患者中两种BRCA1突变(5382insC和300T > G)的患病率。
Fam Cancer. 2017 Oct;16(4):471-476. doi: 10.1007/s10689-017-9978-9.
4
Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience.针对乳腺癌患病风险增加或已被诊断为乳腺癌的犹太女性的信息及支持需求的调查:沙尔谢莱特经验
Healthcare (Basel). 2015 May 22;3(2):324-37. doi: 10.3390/healthcare3020324.
5
Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.癌症相关BRCA1/2突变携带者的心理困扰、焦虑和抑郁:一项系统综述
J Genet Couns. 2016 Oct;25(5):880-91. doi: 10.1007/s10897-016-9949-6. Epub 2016 Apr 14.
6
Should I Perform Genetic Testing? A Qualitative Look into the Decision Making Considerations of Religious Israeli Undergraduate Students.我应该进行基因检测吗?对以色列宗教本科生决策考量的定性研究。
J Genet Couns. 2016 Oct;25(5):1093-115. doi: 10.1007/s10897-016-9942-0. Epub 2016 Mar 15.
7
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine.乌克兰乳腺癌患者中BRCA1始祖突变c.5266dupC(5382insC)的频率。
Hered Cancer Clin Pract. 2015 Oct 13;13:19. doi: 10.1186/s13053-015-0040-3. eCollection 2015.